17 majTIR-C selected for IVA's 100 listTIRmed Pharma's project to developing TIR-C has been listed by Kungliga IngenjörsVetenskapsakademien (IVA) in their annual 100 list as...
27 apr.TIRmed Pharma consortium receives grant of 1.5 MSEK from VinnovaVinnova, together with Swelife and Medtech4health, have jointly called for new innovative projects within life science and medical...
12 sep. 2021TIRmed Pharma initiates permeability study with leading CROTIRmed Pharma have begun a permeability study on their cream targeting Atopic Dermatitis, TIR-C. The study will showcase its ability to...
19 nov. 2020TIRmed Pharma raises 5.4 MSEK in equity for pre-clinical developmentEczema is a common disease affecting up to 20% of children and approximately 3% of adults, with a drugs market estimated up to 75 BSEK...
15 okt. 2020New publicationAmelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide Authors: Aleksandra...